Daiichi Sankyo Co., Ltd. (DSKYF.PK) will transfer yescarta marketing authorization in Japan to Gilead Sciences K.K., the Japan subsidiary of Gilead Sciences Inc. (GILD), in 2023, the companies said in a statement.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,